Address

Other Office
10956 Weyburn Avenue
Suite 222
Los Angeles, CA 90024
United States

Open map


Recent investment activity

KANDO id: 2842

Corporate information

Also known as
Research Corporation Technologies BioVentures
Registration country

Company type

The vehicle through which Research Corporation Technologies invests in start-up or early-stage companies

Relation

Funding rounds

Top investment portfolio themes
healthcare (2)  

Actual initial investment stage
N/A (15)

Investment activity status
Active investor

Selected investments

Displaying 1 - 25 of 40
Profile Country Date Funding
Alerion Biomedical Inc N/A
APT Pharmaceuticals Inc A pharmaceutical company focused on repurposing well-characterized drugs for under-served populations. N/A
Catalyst Biosciences Inc Developer of catalytic biopharmaceutical products based on engineered human proteases. Series A
Clear Catheter Systems N/A
Cylene Pharmaceuticals Inc Clinical stage private company developing small molecule drugs against newly validated cancer targets. N/A
Esperance Pharmaceuticals Inc Company that develops a new class of targeted anticancer drugs that selectively kill cancer cells without harming normal cells. N/A
Fullerene International Corp N/A
Jenrin Discovery Inc Developer of drugs for the treatment of inflammatory and metabolic disorders, including obesity. N/A
Kerberos Proximal Solutions Inc A medical device company that has developed products for improved vascular treatments. N/A
Lacoste & Romberg-Scintrex Inc N/A
NP Photonics Inc N/A
OncoGenex Pharmaceuticals A biopharmaceutical company committed to the development and commercialization of new cancer therapies. N/A
Option 3 LLC Medical device development and commercialization company. N/A
OrthAlign Inc Medical device company providing orthopedic surgeons with user-friendly, cost-effective, surgical navigation products for precise alignment. N/A
ParinGenix Inc N/A
Peptech Ltd N/A
Sertoli Technologies Inc (STI) N/A
Spirogen Ltd Develops potent small molecules based on novel mechanisms and chemistry in the fight to target important cancers. N/A
Therapeutic Human Polyclonals Inc (THP) N/A
VasoNova Inc Leader in algorithm-based vascular navigation and measurement technology. Series B
VasoNova Inc Leader in algorithm-based vascular navigation and measurement technology. N/A
Catalyst Biosciences Inc Developer of catalytic biopharmaceutical products based on engineered human proteases. Series B Initial investment
Clear Catheter Systems N/A Initial investment
Cylene Pharmaceuticals Inc Clinical stage private company developing small molecule drugs against newly validated cancer targets. Series C Initial investment
Cylene Pharmaceuticals Inc Clinical stage private company developing small molecule drugs against newly validated cancer targets. Series A Initial investment

Past employees

Selected Products / Customers

Financials